These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 15474886

  • 1. Essential fatty acids in Huntington's disease.
    Das UN, Vaddadi KS.
    Nutrition; 2004 Oct; 20(10):942-7. PubMed ID: 15474886
    [Abstract] [Full Text] [Related]

  • 2. Essential fatty acids given from conception prevent topographies of motor deficit in a transgenic model of Huntington's disease.
    Clifford JJ, Drago J, Natoli AL, Wong JY, Kinsella A, Waddington JL, Vaddadi KS.
    Neuroscience; 2002 Oct; 109(1):81-8. PubMed ID: 11784701
    [Abstract] [Full Text] [Related]

  • 3. Selective neuronal degeneration in Huntington's disease.
    Cowan CM, Raymond LA.
    Curr Top Dev Biol; 2006 Oct; 75():25-71. PubMed ID: 16984809
    [Abstract] [Full Text] [Related]

  • 4. Blocking acid-sensing ion channel 1 alleviates Huntington's disease pathology via an ubiquitin-proteasome system-dependent mechanism.
    Wong HK, Bauer PO, Kurosawa M, Goswami A, Washizu C, Machida Y, Tosaki A, Yamada M, Knöpfel T, Nakamura T, Nukina N.
    Hum Mol Genet; 2008 Oct 15; 17(20):3223-35. PubMed ID: 18658163
    [Abstract] [Full Text] [Related]

  • 5. Global changes to the ubiquitin system in Huntington's disease.
    Bennett EJ, Shaler TA, Woodman B, Ryu KY, Zaitseva TS, Becker CH, Bates GP, Schulman H, Kopito RR.
    Nature; 2007 Aug 09; 448(7154):704-8. PubMed ID: 17687326
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotective effects of L-carnitine in a transgenic animal model of Huntington's disease.
    Vamos E, Voros K, Vecsei L, Klivenyi P.
    Biomed Pharmacother; 2010 Apr 09; 64(4):282-6. PubMed ID: 19932584
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of 26S proteasome activity by huntingtin filaments but not inclusion bodies isolated from mouse and human brain.
    Díaz-Hernández M, Valera AG, Morán MA, Gómez-Ramos P, Alvarez-Castelao B, Castaño JG, Hernández F, Lucas JJ.
    J Neurochem; 2006 Sep 09; 98(5):1585-96. PubMed ID: 16787406
    [Abstract] [Full Text] [Related]

  • 8. Phosphodiesterase type IV inhibition prevents sequestration of CREB binding protein, protects striatal parvalbumin interneurons and rescues motor deficits in the R6/2 mouse model of Huntington's disease.
    Giampà C, Middei S, Patassini S, Borreca A, Marullo F, Laurenti D, Bernardi G, Ammassari-Teule M, Fusco FR.
    Eur J Neurosci; 2009 Mar 09; 29(5):902-10. PubMed ID: 19291221
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Proteasome impairment does not contribute to pathogenesis in R6/2 Huntington's disease mice: exclusion of proteasome activator REGgamma as a therapeutic target.
    Bett JS, Goellner GM, Woodman B, Pratt G, Rechsteiner M, Bates GP.
    Hum Mol Genet; 2006 Jan 01; 15(1):33-44. PubMed ID: 16311253
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Disruption of the toxic conformation of the expanded polyglutamine stretch leads to suppression of aggregate formation and cytotoxicity.
    Popiel HA, Nagai Y, Onodera O, Inui T, Fujikake N, Urade Y, Strittmatter WJ, Burke JR, Ichikawa A, Toda T.
    Biochem Biophys Res Commun; 2004 May 14; 317(4):1200-6. PubMed ID: 15094397
    [Abstract] [Full Text] [Related]

  • 18. Therapeutic prospects for the prevention of neurodegeneration in Huntington's disease and the polyglutamine repeat disorders.
    Kimura Y, Lee WC, Littleton JT.
    Mini Rev Med Chem; 2007 Jan 14; 7(1):99-106. PubMed ID: 17266642
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.